frrol, would add to your observations that our AVXL investors risk profile appears better every day. As links get drawn between various CNS disease trials-results and progress the cumulative risk for the entire body of work is reduced. A brilliant demonstration of our MOA.
Dr.M.,Focusing on activation of the body’s own defense mechanism to provide support to avoid or reduce the stress which can be part of these diseases.
Each CNS AVXL disease win begets another while simultaneously reducing investors risk profile. BRILLIANT...it gets better because it is getting better...a kind of positive thermal risk reduction runaway phenom....NICE.